Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
4
Filing Date
2/11/2024
Updated
2/12/24, 1:22 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership